Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Edoardo
    Junior Member
    • Mar 2016
    • 2

    #1

    Problem using SnpEff after Transdecoder: large number of warnings

    Hi,
    I am a PhD student with very little experience in bioinformatics (or very little experience at all, I started two months ago).
    I’m having some problems getting Snpeff to work with gff coordinates obtained by Transdecoder.
    I was given by a group with which I am collaborating the assembly of a genome and a gtf file with transcript information derived from RNAseq. I used Transdecoder following the instructions, with the –single_best_orf option, and I got the cds file and a gff3.
    I used the gff3 to build a database for snpeff, because I have to evaluate the effect of some SNPs on the genome. Howevere, when I launched Snpeff eff, I received a great number of warnings:

    INFO_REALIGN_3_PRIME 1
    WARNING_TRANSCRIPT_NO_START_CODON 202855
    WARNING_TRANSCRIPT_NO_START_CODON&INFO_REALIGN_3_PRIME 2
    WARNING_TRANSCRIPT_NO_STOP_CODON 17281

    Protein coding transcripts : 2426
    # Length errors : 0 ( 0,00% )
    # STOP codons in CDS errors : 0 ( 0,00% )
    # START codon errors : 686 ( 28,28% )
    # STOP codon warnings : 183 ( 7,54% )
    # UTR sequences : 2409 ( 99,30% )
    # Total Errors : 686 ( 28,28% )

    Given the low number of transcripts, this amount of warnings seems to be extremely high. Is it normal?
    Also, I checked the CDSs obtained by Transdecoder and, even if not all of them start with ATG, all of them have a start codon near the beginning of the sequence, so I really cannot explain this number of warnings.
    Do you have any suggestions?
    May the life of he/she who comes to my aid be filled with cakes and pizzas.
    Best Regards
    Edoardo

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...